Novo Nordisk has just announced that their drug liraglutide is extremely effective at inducing weight loss among people suffering from type 2 diabetes. In a 56-week long double-blind phase 3a clinical trial, part of the SCALETM (Satiety and Clinical Adiposity Liraglutide Evidence in Non-diabetic...
Check Out The Entire News Here
No comments:
Post a Comment